Fig. 5

Immunotherapy prediction using the TIDE algorithm. a Differences in response to immunotherapy among subtypes; b TIDE score, c dysfunction score, d exclusion score, e myeloid-derived suppressor cell (MDSC), f cancer-associated fibroblast (CAF), and g M2 macrophages score in TCGA cohort. h Differences in response to immunotherapy among subtypes; i TIDE score, j dysfunction score, k exclusion score, l MDSC, m CAF, and n M2 macrophages score in the GSE32894 cohort